DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Sarcosine is an investigational drug.
There have been 14 clinical trials for Sarcosine. The most recent clinical trial was a Phase 2 trial, which was initiated on September 1st 2012.
The most common disease conditions in clinical trials are Schizophrenia, Psychotic Disorders, and Mental Disorders. The leading clinical trial sponsors are China Medical University Hospital, National Science Council, Taiwan, and University of Aarhus.
There are two US patents protecting this investigational drug and twenty-five international patents.
Recent Clinical Trials for Sarcosine
|Effect of Obeticholic Acid on Transport of Bile Acids in PBC Examined by 11C-cholyl-sarcosine PET/CT||University of Aarhus||Early Phase 1|
|Carbon-11 Labeled Sarcosine in Prostate Cancer||National Cancer Institute (NCI)||N/A|
|Carbon-11 Labeled Sarcosine in Prostate Cancer||National Institutes of Health (NIH)||N/A|
Top disease conditions for Sarcosine
Top clinical trial sponsors for Sarcosine
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Sarcosine||Start Trial||Mild skin cleansing aerosol mousse with skin feel and moisturization benefits||The Procter & Gamble Company (Cincinnati, OH)||Start Trial|
|Sarcosine||Start Trial||Delivery system||Alza Corporation (Palo Alto, CA)||Start Trial|
|Sarcosine||Start Trial||Compositions containing phosphonitrile chlorides||Wacker-Chemie GmbH (Munich, DE)||Start Trial|
|Sarcosine||Start Trial||General method for producing and selecting peptides with specific properties||The Regents of the University of California (Oakland, CA)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|